We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Road test

3 Nov 2021 By Aimee Donnellan

German diagnostic group Qiagen and French peer BioMerieux may merge, Bloomberg says. A $28 bln deal would allow both companies to offer more products and better cope with the end of the pandemic boom. But few synergies and integration risks open the door to other predators.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)